Chappaqua, NY, United States of America

David B Cross

This inventor holds 1 USPTO granted patent. Top assignee: Cellhealth Technologies Ltd.. Active years: 2016.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of David B Cross

Introduction

David B Cross is a notable inventor based in Chappaqua, NY (US). He has made significant contributions to the field of health and wellness through his innovative patent. His work focuses on supplement compositions that support telomere maintenance and protection, which is crucial for cellular health.

Latest Patents

David B Cross holds a patent for a supplement composition designed to support telomere maintenance and protection. This patent includes a unique blend of ingredients such as N-acetylcysteine, Resveratrol, Puerarin, and L-arginine. The method disclosed in the patent involves orally administering the supplement composition to individuals once or twice daily, with specific dosages for each ingredient to ensure effectiveness.

Career Highlights

Throughout his career, David has been dedicated to advancing health solutions through innovative research and development. His work at Cellhealth Technologies Ltd. has positioned him as a key player in the health supplement industry. His focus on telomere maintenance reflects a growing interest in longevity and cellular health.

Collaborations

David B Cross collaborates with Vincent C Giampapa, a fellow innovator in the field. Their partnership emphasizes the importance of teamwork in developing effective health solutions.

Conclusion

David B Cross exemplifies the spirit of innovation in health and wellness through his patent and contributions to the field. His work continues to inspire advancements in supplement formulations aimed at improving cellular health and longevity.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…